Concomitant FARAPULSE and WATCHMAN: The Patient, the Procedure, and the Data-Concomitant FARAPULSE and WATCHMAN: The Patient, the Procedure, and the Data

Video Transcription

Video Summary

In this theater session, experts in electrophysiology discussed the growing demand for the concomitant procedure, which integrates pulse field ablation (PFA) with the Watchman device. This approach is particularly popular in places like Salt Lake City, driven by both patient and referring physician interest. The panel included leaders like Dr. Amin Al-Ahmad, Devi Nair, and Waleed Saliba, who shared their insights on the procedure's benefits in improving patient care by reducing multiple interventions, minimizing procedural risks, and improving outcomes.<br /><br />The session outlined the promising data from the Option study, which showed the efficacy and safety of using the Watchman Flex device in preventing thromboembolic events and reducing bleeding compared to oral anticoagulation. Challenges such as edema during concomitant procedures were discussed, with emphasis on how pre-procedural planning and imaging are crucial for success. The use of advanced technologies, including the Farapulse and Faradrive systems, was highlighted for their role in improving procedural efficiency and outcomes.<br /><br />Audience polls suggested a strong belief in increased use of both Watchman and PFA procedures, reflecting current trends and anticipated growth. Future clinical trials like Option A and Align AF, which aim to provide further data on concomitant procedures, were noted as exciting opportunities for the field. The session concluded with optimism about the role these innovations will play in advancing patient care in electrophysiology.

Keywords

electrophysiology

pulse field ablation

Watchman device

Salt Lake City

patient care

Option study

thromboembolic events

Farapulse system

clinical trials

concomitant procedures